DRKS00017515
Completed
Not Applicable
Clinical characterization of arrhythmia-induced tachymyopathy (AIC)
niversitätsklinikum Regensburg0 sites68 target enrollmentSeptember 30, 2019
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- I42.9
- Sponsor
- niversitätsklinikum Regensburg
- Enrollment
- 68
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Suptraventricular tachycardia (100/min), unexplained left ventricular systolic dysfunction (LVEF \<50%), rhythm control strategy, age \>18y, informed consent.
Exclusion Criteria
- •History of previous significant non AIC\-LVSD (EF\<50%), myocardial infarction within the last 3 months. Long persistent or permanent AF.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Occurrence and predictors of irregular heart rhythms and sudden cardiac death in the first 48hours after a heart attackHealth Condition 1: I21- Acute myocardial infarctionCTRI/2024/01/061723Dr Sreeja Gandamsetty
Not yet recruiting
Not Applicable
Circuits of atrioventricular nodal reentrant tachycardiaatrioventricular nodal reentrant tachycardia (AVNRT)JPRN-UMIN000052988AOI Universal Hospital25
Active, not recruiting
Phase 1
Clinical Effects Of Continuous Infusion Of Propofol In Adults With Brugada Syndrome.EUCTR2019-004750-28-BEniversitair Ziekenhuis Brussel5
Recruiting
Not Applicable
Clinical Effectiveness of Atrial Anti-tachycardia Pacing Therapy in Sick Sinus Syndrome with Previous Atrial Fibrillation Ablation (CEASE-AF)Sick sinus syndromeAtrial FibrillationCardiovascular - Other cardiovascular diseasesACTRN12616001353482Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital136
Completed
Not Applicable
Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmiasFetal tachyarrythmia (Supraventricular tachycardia, Atrial flutter)JPRN-UMIN000026378Gunma University Hospital5